Editorial: Personalized management of acromegaly

Editorial: Personalized management of acromegaly

Bibliographic Details
Main Author:	Nicholas A. Tritos
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Endocrinology
Subjects:	acromegaly pituitary adenoma medical therapy surgery radiation therapy growth hormone
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1214152/full

Similar Items

Recurrent Acromegaly in a Patient With a CHEK2 Mutation
by: Milica Perosevic, MD, et al.
Published: (2022-03-01)

Intraoperation haemorrhage into hypophysis adenoma as the cause of acromegaly remission
by: V N Azizyan, et al.
Published: (2011-03-01)

Acromegaly: a clinical perspective
by: Lima Lawrence, et al.
Published: (2020-08-01)

Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report
by: Sasan Mirfakhraee, et al.
Published: (2021-04-01)

Acromegaly associated with a symptomatic Rathke′s cyst
by: Vishal Gupta, et al.
Published: (2011-01-01)

The Role of Soluble α-klotho Protein in Acromegaly
by: Oana PINZARIU, et al.
Published: (2023-03-01)

Characteristics of Acromegaly in Korea with a Literature Review
by: Jae Won Hong, et al.
Published: (2013-09-01)

The Biochemical Diagnosis of Acromegaly
by: Amit Akirov, et al.
Published: (2021-03-01)

The development remission of acromegaly in the outcome of intraoperative bleeding in somatoprolactinomas
by: A Y Grigorev, et al.
Published: (2012-06-01)

Difficulties in diagnosis of adenomas with mixed prolactin and growth hormone secretion: case presentation
by: Larisa K. Dzeranova, et al.
Published: (2020-12-01)

Robotic Radiosurgery for Persistent Postoperative Acromegaly in Patients with Cavernous Sinus-Invading Pituitary Adenomas—A Multicenter Experience
by: Felix Ehret, et al.
Published: (2021-01-01)

Evaluation of Factors Affecting Outcome in Growth Hormone–Secreting Pituitary Adenomas
by: Amit Padwal, et al.
Published: (2017-09-01)

Changes in acromegaly comorbidities, treatment, and outcome over three decades: a nationwide cohort study
by: Christian Rosendal, et al.
Published: (2024-04-01)

Surgical Outcome and Evaluation of Strategies in the Management of Growth Hormone-Secreting Pituitary Adenomas After Initial Transsphenoidal Pituitary Adenectomy Failure
by: Jiun-Lin Yan, et al.
Published: (2022-04-01)

Presence of cerebral microbleeds is associated with cognitive decline in acromegaly
by: Zhengxing Xie, et al.
Published: (2022-11-01)

Surgery for acromegaly: Indications and goals
by: David P. Bray, et al.
Published: (2022-08-01)

Assessment of anthropometric and physical health indicators before and after pituitary surgery in patients with nonfunctioning pituitary adenomas, acromegaly, and Cushing disease
by: Cyro G S. Leães, et al.
Published: (2019-01-01)

Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors
by: Antonio Bianchi, et al.
Published: (2023-05-01)

Thymic hyperplasia due to excess growth hormone stimulation: A case report
by: Claire Brookmeyer, MD, et al.
Published: (2022-04-01)

Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs)
by: Alessandro Brunetti, et al.
Published: (2022-06-01)

Aspectos dermatológicos da acromegalia Dermatologic aspects in acromegaly
by: Maurício Zanini, et al.
Published: (2004-08-01)

Acromegaly: a challenging condition to diagnose
by: AlDallal S
Published: (2018-08-01)

PREVALENCE OF SLEEP DISORDERED BREATHING IN PATIENTS WITH NEWLY DIAGNOSED ACROMEGALY
by: U. A. Tsoy, et al.
Published: (2016-02-01)

Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine
by: Kyungwon Kim, et al.
Published: (2023-10-01)

Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?
by: Cheol Ryong Ku, et al.
Published: (2020-06-01)

Reappraisal of microscopic microsurgical transsphenoidal surgery for GH-secreting pituitary macroadenoma in patients with acromegaly: Historical data from Vietnam (2010–2013)
by: Ngo Manh Hung, et al.
Published: (2020-12-01)

Long-term follow-up of patients with surgical intractable acromegaly after linear accelerator radiosurgery
by: Jiun-Lin Yan, et al.
Published: (2013-07-01)

Pasireotide in the Personalized Treatment of Acromegaly
by: Manel Puig-Domingo, et al.
Published: (2021-03-01)

Pathogenic relations between metabolic and gynecologic disorders in acromegaly: a clinical case report
by: Alexander S. Lutsenko, et al.
Published: (2017-11-01)

Treatment experience of intractable headache in patients with growth hormone ⁃ secreting pituitary adenoma
by: Yi⁃ding FENG, et al.
Published: (2020-03-01)

Complications and Comorbidities of Acromegaly—Retrospective Study in Polish Center
by: Małgorzata Rolla, et al.
Published: (2021-03-01)

Advancing Treatment of Pituitary Adenomas through Targeted Molecular Therapies: The Acromegaly & Cushing Disease Paradigms
by: Michael Anthony Mooney, et al.
Published: (2016-07-01)

Hemorrhage into a somatotropinoma аs a first reason for examination of a patient with previously undiagnosed acromegaly and papillary thyroid cancer
by: Guzel M. Nurullina, et al.
Published: (2023-06-01)

Recurrent Kidney Stone Episodes Leading to a Diagnosis of Occult Acromegaly
by: Julie N. Thai, et al.
Published: (2017-09-01)

Pulmonary epidermoid carcinoma in a patient with acromegaly: a rare entity
by: Siham El Aziz, et al.
Published: (2012-06-01)

Acromegaly - dealing with an uncooperative patient
by: Michał Obel, et al.
Published: (2020-10-01)

Postoperative structural complications after microscopic transsphenoidal surgery of GH secreting pituitary adenomas
by: Marcelo Lemos Vieira da Cunha, et al.
Published: (2013-12-01)

The Therapeutic Effect of Endoscopic Tumor Resection on Acromegalic Cardiomegaly in Patients With Pituitary Adenoma
by: Kaveh Ebrahimzadeh, et al.
Published: (2020-01-01)

Screening for germline KCNQ1 and KCNE2 mutations in a set of somatotropinoma patients
by: Anna-Pauliina Iivonen, et al.
Published: (2018-04-01)

Preoperative treatment of growth hormone (GH) producing macroadenomas with somatostatin receptor ligands (SRLs) to improve surgical outcome: a critical analysis
by: Ariel Barkan
Published: (2018-07-01)